Fondazione Irccs Istituto Nazionale Dei Tumori, Milano
Clinical trials sponsored by Fondazione Irccs Istituto Nazionale Dei Tumori, Milano, explained in plain language.
-
New program aims to shield smokers from cancer with pill, quit aid, diet, and exercise
Prevention OngoingThis study is testing a comprehensive prevention program for long-term smokers aged 55-75. The program combines low-dose aspirin, a quit-smoking medication, a Mediterranean-style diet, and increased physical activity, along with annual lung scans. The goal is to see if this multi…
Phase: PHASE2 • Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Prevention
Last updated Mar 30, 2026 14:27 UTC
-
AI joins the fight: using scans and blood tests to personalize kidney cancer care
Knowledge-focused OngoingThis study aims to find better ways to match patients with newly diagnosed metastatic kidney cancer to the most effective first treatment. Researchers will collect blood, tumor tissue, and CT scans from 100 patients to look for patterns. They will use computer analysis to try to …
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:40 UTC
-
Massive national study maps rare inherited colon disease
Knowledge-focused OngoingThis study is creating a national Italian registry to track patients with inherited conditions that cause many colon polyps and high cancer risk. It will follow about 1,500 patients to collect detailed information on how their disease progresses, what treatments they receive, and…
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:41 UTC